Smith Natalie J, Maddahfar Mahnaz, Gunasegaran Bavani, McGuire Helen M, Fazekas de St Groth Barbara
University of Sydney, Camperdown, NSW, Australia.
University of Technology Sydney, Ultimo, NSW, Australia.
Methods Mol Biol. 2023;2620:273-286. doi: 10.1007/978-1-0716-2942-0_29.
Arginase, an enzyme involved in the urea cycle, is gaining attention as a critical player in numerous chronic pathologies. Additionally, increased activity of this enzyme has been shown to correlate with poor prognosis in a range of cancers. Colorimetric assays that measure the conversion of arginine to ornithine have long been used to determine the activity of arginase. However, this analysis is hindered by a lack of standardization across protocols. Here, we describe in detail a novel revision of the Chinard's colorimetric assay used to determine arginase activity. Dilution series of patient plasma are plotted to form a logistic function, from which activity can be interpolated by comparison to an ornithine standard curve. Inclusion of patient dilution series rather than a single point increases the robustness of the assay. This high-throughput microplate assay analyzes 10 samples per plate to produce highly reproducible results.
精氨酸酶是一种参与尿素循环的酶,作为众多慢性疾病中的关键参与者正受到关注。此外,已证明这种酶活性的增加与一系列癌症的不良预后相关。长期以来,用于测量精氨酸向鸟氨酸转化的比色测定法一直被用于确定精氨酸酶的活性。然而,该分析受到各方案缺乏标准化的阻碍。在此,我们详细描述了用于确定精氨酸酶活性的Chinard比色测定法的一种新修订。绘制患者血浆的稀释系列以形成逻辑函数,通过与鸟氨酸标准曲线比较可从中插值得出活性。纳入患者稀释系列而非单个点可提高测定的稳健性。这种高通量微孔板测定法每板分析10个样本以产生高度可重复的结果。